Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence

Journal of Clinical Oncology

Volumn 21, Issue 3, 2003, Pages 447-452

  Yamamoto, Shinji ^a   Tomita, Yasuhiko ^a   Nakamori, Shoji ^a   Hoshida, Yoshihiko ^a   Nagano, Hiroaki ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Monden, Morito ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P97; VALOSIN CONTAINING PROTEIN; CDC48 PROTEIN; CELL CYCLE PROTEIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LIVER CIRRHOSIS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037313833     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.068     Document Type: Article

References (35)

1. Parkin DM, Whelan SL, Ferlay J, et al (eds): Cancer Incidence in Five Continents (vol VII). Lyon, France, International Agency for Research on Cancer, 1997
2. Edmondson H, Steiner P: Primary carcinoma of the liver: A study of 100 cases among 48, 900 necropsy. Cancer 7:462-503, 1954
3. Beasley RP: Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956, 1988
4. Okuda K, Fujimoto I, Hanai A, et al: Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967-4972, 1987
5. Simonetti RG, Cottone M, Craxi A, et al: Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2:1338, 1989
6. Di Bisceglie A: Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 15:64-69, 1995
7. Fong Y, Sun RL, Jarnagin W, et al: An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790-799, 1999
8. The Liver Cancer Study Group of Japan: Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74:2772-2780, 1994
9. Lai EC, Fan ST, Lo CM, et al: Hepatic resection for hepatocellular carcinoma: An audit of 343 patients. Ann Surg 221:291-298, 1995
10. Lau H, Fan ST, Ng IO, et al: Long term prognosis after hepatectomy for hepatocellular carcinoma: A survival analysis of 204 consecutive patients. Cancer 83:2302-2311, 1998
11. Takenaka K, Kawahara N, Yamamoto K, et al: Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131:71-76, 1996
12. Poon RT, Fan ST, Ng IO, et al: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500-507, 2000
13. Lauwers GY, Vauthey JN: Pathological aspects of hepatocellular carcinoma: A critical review of prognostic factors. Hepatogastroenterology 3:1197-1202, 1998
14. Shimada M, Takenaka K, Taguchi K, et al: Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80-85, 1998
15. Shimada M, Hasegawa H, Gion T, et al: Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy. Hepatogastroenterology 46:2469-2475, 1999
16. Sobin LH, Wittekind CH: TNM classification of Malignant Tumors (ed 5). New York, NY, Wiley, 1997, pp 74-77
17. Adachi E, Maeda T, Matsumata T, et al: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108:768-775, 1995
18. Asai T, Tomita Y, Nakatsuka S, et al: VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 93:296-304, 2002
19. Dai RM, Chen E, Longo DL, et al: Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273:3562-3573, 1998
20. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 276:60-66, 1997
21. Couinaud C: Lobes et segments hepatiques: Note sur l'architecture anatomique et chirurgicale du foie. Presse Med 62:709-711, 1954
22. Knodell RG, Ishak KG, Black WC, et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
23. Holland PM, Abramson RD, Watson R, et al: Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 88:7276-7280, 1991
24. Heid CA, Stevens J, Livak KJ, et al: Real time quantitative PCR. Genome Res 6:986-994, 1996
25. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Cox DR: Regression models and life tables. J R Stat Soc 34:197-220, 1972
27. Ng IO: Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J Gastroenterol Hepatol 13:666-670, 1998
28. Ko S, Kanehiro H, Hisanaga M, et al: Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89:57-62, 2002
29. Tietze MK, Wuestefeld T, Paul Y, et al: IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas. Cancer Gene Ther 7:1315-1323, 2000
30. Kirimlioglu H, Dvorchick I, Ruppert K, et al: Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology 30:502-510, 2002
31. Ono T, Yamanoi A, Nazmy, et al: Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: Meta-analysis of three randomized controlled trials. Cancer 91:2378-2385, 2001
32. Muto Y, Moriwaki H, Ninomiya M, et al: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma: Hepatoma Prevention Study Group. N Engl J Med 334:1561-1567, 1996
33. Kubo S, Nishiguchi S, Hirohashi K, et al: Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 89:418-422, 2002
34. Takayama T, Sekine T, Makuuchi M, et al: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial. Lancet 356:802-807, 2000
35. Sakon M, Nagano H, Dono K, et al: Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94:435-442, 2002